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Abstract: Polyethylenimine (PEI), especially PEI 25 kDa, has been widely studied for delivery 
of nucleic acid drugs both in vitro and in vivo. However, it lacks degradable linkages and is 
too toxic for therapeutic applications. Hence, low-molecular-weight PEI has been explored as 
an alternative to PEI 25 kDa. To reduce cytotoxicity and increase transfection efficiency, we 
designed and synthesized a novel small-molecular-weight PEI derivative (PEI-Et, Mn: 1220, 
Mw: 2895) with ethylene biscarbamate linkages. PEI-Et carried the ability to condense plas-
mid DNA (pDNA) into nanoparticles. Gel retardation assay showed complete condensation 
of pDNA at w/w ratios that exceeded three. The particle size of polymer/pDNA complexes 
was between 130 nm and 180 nm and zeta potential was 5–10 mV , which were appropriate 
for cell endocytosis. The morphology of PEI-Et/pDNA complexes observed by atomic force 
microscopy (AFM) was spherically shaped with diameters of 110–190 nm. The transfection 
efficiency of polymer/pDNA complexes as determined with the luciferase activity assay as well 
as fluorescence-activated cell-sorting analysis (FACS) was higher than commercially available 
PEI 25 kDa and Lipofectamine 2000 in various cell lines. Also, the polymer exhibited signifi-
cantly lower cytotoxicity compared to PEI 25 kDa at the same concentration in three cell lines. 
Therefore, our results indicated that the PEI-Et would be a promising candidate for safe and 
efficient gene delivery in gene therapy.
Keywords: gene delivery, polyethylenimine, nanoparticles, cytotoxicity, transfection 
efficiency
Introduction
Gene therapy, the introduction of an extraneous gene into the target cells or organs with 
the aim of replacing a lost cellular function or introducing a new functionality, offers 
tremendous promise for the treatment of many inherited and acquired diseases. An 
efficient and safe delivery system that delivers the therapeutic gene to a specific target 
tissue or organ is the prerequisite for successful gene therapy.1,2 Gene delivery vectors 
are classified into two categories: viral and nonviral vectors. Although with lower effi-
ciency when compared with viral vectors,3 nonviral alternatives have been developed as 
safer strategies for gene delivery owing to several advantages over viral vectors, includ-
ing safety, lower immunogenicity, the ease of chemical modification and the ability to 
transfer larger plasmid DNA (pDNA) molecules.4–6 Nonviral vectors can be divided into 
two categories: cationic polymers and cationic lipid carriers. Cationic polymer/pDNA 
complexes tend to be more stable than cationic lipid/pDNA complexes.7
Recently, the cationic polyethylenimine (PEI) has been widely used for nonviral 
transfection. PEI effectively condenses pDNA into nanoparticles and holds capacity 
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for transfecting a variety of cell lines both in vitro and in vivo 
by force of a proton sponge effect, which prevents the pDNA 
from endosomal disruption.8,9 The molecular weight of PEI 
is a critical factor influencing the toxicity and transfection 
efficiency.10 Low-molecular-weight PEI (,2 kDa) was 
proven to be nontoxic, ineffectively condensing pDNA, and 
displaying very poor transfection activity. In contrast, PEI 
with higher molecular weight (25 kDa) exhibited higher 
transfection efficiency and yet higher toxicity than other 
low-molecular-weight PEIs.11,12 In addition, PEI 25 kDa 
with the structure containing C–C or C–N bonds was totally 
nonbiodegradable, which would give rise to accumulative 
cytotoxicity in vivo. Taken together, the long-term safety of 
high-molecular weight PEI is further problematic.   Therefore, 
to address the conflict, several modified PEI such as 
PEGylation,13,14 acylation15 of high molecular weight and 
cross-linked low-molecular-weight PEIs with biodegradable 
linkages (ester,16,17 disulfide,18 and amide,19 linkages, etc) 
have been investigated as gene carriers to increase its gene 
delivery efficiency and reduce cytotoxicity. Recently, Zhao 
and colleagues20 synthesized biodegradable PEI–triethylene 
glycol (TEG) based on PEI 2 kDa and TEG through biscar-
bamate linkages. They reported that the polymer could be 
degraded in neutral environment and exhibited high trans-
fection ability with low toxicity compared to PEI 25 kDa. 
Previously, we also introduced butyl biscarbamate cross-
linked PEI derivative (PEIC) with small molecular weight, 
which displayed higher transfection efficiency and lower 
cytotoxicity compared to PEI 25 kDa in COS-7 cells. PEIC 
exhibited the highest gene transfection efficiency when the 
PEIC/pDNA weight ratio (w/w) was 40.21
In this paper, we designed and synthesized a novel cross-
linked PEI derivative with ethylene biscarbamate linkage 
(PEI-Et). PEI-Et was synthesized and characterized with 
proton nuclear magnetic resonance (1H-NMR), Fourier 
transform-infrared (FT-IR), and gel permeation chromatog-
raphy (GPC). Then PEI-Et/pDNA complexes were prepared 
and characterized in terms of particle size, zeta potential, 
pDNA condensation ability, and morphology under atomic 
force microscope (AFM). In addition, the cytotoxicities of 
the polymer were determined with cell viability assay, the 
transfection efficiencies of PEI-Et/pDNA complexes were 
evaluated in several cell lines including COS-7, HeLa, 
and BRL-3A cells with luciferase activity assay as well as 
fluorescence microscopy and fluorescence-activated cell-
sorting analysis (FACS). PEI-Et also had small molecular 
weight compared with PEI 25 kDa. In comparison to PEIC’s 
best transfection performance at PEIC/pDNA w/w of 40 in 
COS-7 cell lines, PEI-Et/pDNA complexes exhibited best 
transfection activity with w/w ranging 10–20 in different cell 
lines, which would favor its further functional gene inves-
tigation due to the decreased w/w ratio. In addition, PEI-Et 
displayed lower toxicity than PEIC in COS-7 and BRL-3A 
cell lines (data not shown). Our results demonstrated that 
PEI-Et had the potential to be a promising candidate as a 
nonviral gene carrier.
Materials and methods
Materials
Branched PEI (25 kDa, 800 Da), ethylene bis(chloroformate), 
ethidium bromide (EB), and 3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazoliumbromide (MTT) were purchased from 
Sigma-Aldrich (St Louis, MO). MicroBCA protein assay kit 
was obtained from Pierce (Rockford, IL). Luciferase assay 
kit was purchased from Promega (Madison, WI). All other 
chemicals were of analytical grade.
Dulbecco’s modified Eagle’s medium (DMEM), fetal 
bovine serum (FBS) and Trypsin-EDTA were obtained from 
PAA (Cölbe, Germany). The plasmids used in the study 
were pGL3-Control (Promega) encoding firefly luciferase 
and pEGFP-N1 (Clontech, Palo Alto, CA)   encoding 
enhanced green fluorescent protein (EGFP). The purity of the 
  plasmids was checked by electrophoresis on a 1%   agarose 
gel, and the concentration of pDNA was determined by 
  spectrophotometry (A260/A280).
Cell culture
The cell lines COS-7 (African green monkey kidney fibro-
blast) BRL-3A (normal rat liver cell), and HeLa (human 
cervix epithelial carcinoma cell) were purchased from the 
Cell Bank of the Chinese Academy of Sciences (Shanghai, 
China) and cultured in DMEM medium supplemented with 
10% FBS. Cells were maintained at 37°C in a humidified 
5% CO2 incubator.
Synthesis of PEI-Et
Branched PEI, 800 Da in average molecular weight (Mw), 
and ethylene bis(chloroformate) were respectively dis-
solved in freshly anhydrous chloroform. The ethylene 
bis(chloroformate) solution (10 mg/mL, 18.7 mL) was added 
dropwise to a PEI solution (300 mg/mL, 3 mL) with stirring. 
The reaction was carried out in an ice bath in a nitrogen 
atmosphere and allowed to proceed overnight. Then the 
sample was evaporated under reduced pressure to remove 
the solvent and vacuum-dried for 24 hours. The sample was 
subsequently dissolved in water and dialyzed against distilled 
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water in a dialysis tube (MWCO: 1000 Da) for 2 days and 
lyophilized to yield the polymer. The polymer was stored 
at −20°C for further use.
Characterization of polymer
PEI-Et was estimated by measuring proton nuclear magnetic 
resonance (1H-NMR) (Mercury Plus 400; Varian Inc, Palo 
Alto, CA) and FT-IR. 1H-NMR spectra was recorded on a 
Varian Unity 300 MHz spectrometer (Varian Inc) using D2O 
as a solvent. The FT-IR spectrum of polymer was recorded 
in pressed KBr pellets on a FT-IR spectrometer (Equinox 55; 
Bruker Optics, Bruck, Germany). The molecular weight of 
the polymer was measured by GPC relative to PEG standards 
(Mw range Mp: 106, 430, 633, 1400, 4290, 7130, 12,600, 
20,600 Da), using a Waters high-pressure liquid chromatog-
raphy (HPLC) system (Milford, MA) equipped with a gel 
permeation column (GPC) and a refractive index detector. 
The HPLC mobile phase was ultrapure water.
Preparation of PEI-Et/pDNA complexes
PEI-Et/pDNA complexes were freshly prepared prior to use. 
Briefly, both PEI-Et and pDNA were separately diluted to the 
appropriate concentration in phosphate-buffered saline (PBS; 
pH 7.4, mimicking pH in physiological condition) depending 
on the required w/w ratio, then the complexes were prepared 
by adding polymer solutions to equal volumes of pDNA 
with gentle vortexing and incubated at room temperature for 
30 minutes before use.
Gel retardation assay
The pDNA condensation ability of the polymer was evalu-
ated by agarose gel electrophoresis with plasmid of enhanced 
green fluorescent protein (pEGFP). PEI-Et/pDNA and PEI 
800 Da/pDNA complexes were prepared at various w/w 
ratios from 1 to 30. After incubation for 30 minutes at room 
temperature, the complexes were mixed with appropriate 
amounts of 5 × gel-loading buffer and then electrophore-
sed on 1% (w/v) agarose gels containing EB (0.5 µg/mL 
of the gel) with 1 × Tris-acetate (TAE) buffer at 80 V for 
40 minutes. The locations of the pDNA bands were visualized 
with a UV illuminator (Fisher Biotec, Australia).
Particle size and zeta potential 
measurements
The particle size and zeta potential of complexes were 
  measured using a particle size analyzer (90Plus; Brookhaven, 
Holtsville, NY). PEI-Et/pDNA and PEI 800 Da/pDNA 
  complexes were prepared at various w/w ratios from 
0.5 to 30. The measurement was performed at 25°C with 
a scattering angle of 90° and an electric field strength of 
7 V/cm. Each sample was performed in triplicate.
Atomic force microscopy
The morphology of complexes at w/w ratio 20 was observed 
by atomic force microscopy (AFM). One drop of the 
complexes was placed on a mica disk, and dried at room 
  temperature. Then it was examined under AFM (E-Sweep; 
SII Nanotechnology, Inc, Chiba, Japan). The images were 
taken in air under tapping mode with standard 125-mm 
single-crystal silicon cantilevers.
Cytotoxicity assay
MTT assay was employed to measure the cytotoxicity of the 
polymer, with PEI 25 kDa as a control. Cells were seeded 
in 96-well plates at an initial density of 5000 cells/well in 
100 µL of DMEM containing 10% FBS. After incubation 
for 24 hours, the media were replaced with fresh serum-free 
DMEM containing polymers at various concentrations or 
polymer/pDNA complexes at various w/w ratios (2, 5, 10, 
20, 30, 50). After an additional incubation for 4 hours, the 
media were changed with fresh serum-free DMEM and 25 µL 
of stock solution of MTT (5 mg/mL in PBS) was added to 
each well. The cells were incubated for a further 6 hours, 
afterwards, the media were removed and 150 µL of dimethyl 
sulfoxide (DMSO) was added to the well, the plates were 
mildly shaken for 15 minutes to ensure the dissolution of 
formazan. Finally, the absorbance was measured using an 
ELISA reader (MK3; Thermo Labsystem, Vantaa, Finland) 
at 570 nm (with 630 nm as a reference wavelength). The cell 
viability was expressed as a percentage of the absorbance 
to that of the control experiment without polymers. Five 
replicates were counted for each sample.
Transfection experiments in vitro
Luciferase activity assay
PEI-Et-mediated transfections were evaluated in COS-7, 
BRL-3A, and HeLa cells by using the reporter plasmid 
  pGL3-control. Cells were seeded in 48-well plates at an initial 
density of 5 × 104 cells/well in 500 mL of DMEM contain-
ing 10% FBS. After incubation for 24 hours, The cells were 
washed with PBS followed by the addition of serum-free or 
serum-containing DMEM with polymer/pGL3-control (500 ng) 
complexes at various w/w ratios and additionally incubated 
for 4 hours. Cells transfected with naked pDNA were used 
as negative control, cells transfected with PEI 25 kDa/pDNA 
(  optimal w/w), Lipofectamine 2000/pDNA (optimal w/w), and 
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PEI 800 Da/pDNA were used as positive controls. Afterwards, 
the media were exchanged for 500 mL of fresh DMEM con-
taining 10% FBS and allowed to incubate for 44 hours. Then 
the cells were washed with PBS before adding 75 µL of cell 
lysis buffer, and incubated for 30 minutes. The luciferase assay 
was carried out according to the manufacturer’s instructions 
(  Promega). The relative light units (RLU) of luciferase expres-
sion were measured with a luminometer. The protein concentra-
tion in the cell lysates was measured by MicroBCA protein assay 
kit. The luciferase activity was expressed in terms of RLU/mg 
protein. Each sample was performed in triplicate.
Fluorescence microscopy and fluorescence-activated 
cell-sorting analysis
The optimal w/w ratio of PEI-Et/pEGFP-N1 complexes 
in HeLa cells as determined from the luciferase activity 
assay was selected for this experiment. The levels of green 
  fluorescent protein (GFP) expression were characterized 
using fluorescence microscopy (Olympus, Tokyo, Japan). 
The transfection efficiency was quantified by the percentage 
of cells expressing GFP and analyzed by flow cytometry 
using a FACS Caliber System from Becton-Dickinson (San 
Jose, CA). The data was calculated based on measurements 
from three individual experiments.
Statistical analysis
All statistical analyses were performed with SPSS software 
(v 19.0; SPSS Inc, Chicago, IL). Data were illustrated as 
mean ± standard deviation. Student’s t-test (two-tailed) was 
applied to test the significance of the differences between 
two groups. Data were considered significant difference at 
the level of P , 0.05 and very significant difference at the 
level of P , 0.01.
Results and discussion
Synthesis and characterization  
of polymer
PEI-Et was synthesized through the conjugation of ethylene 
bis(chloroformate) to PEI 800 Da (Figure 1). The struc-
ture of PEI-Et was confirmed using  1H-NMR and FT-IR. 
In   Figure 2A, peak a was from the methylene protons of 
(–CH2CH2 NH–) in PEI 800 Da. As for Figure 2B, peak 
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Figure 1 Reaction scheme of PEI-Et.
Abbreviations: PEI, polyethylenimine; PEI-Et, PEI derivative with ethylene biscarbamate linkage.
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a was attributed to the protons of (–OCOCH2CH2OCO–), 
peaks b and c were from the methylene protons of 
(–NH–CH2CH2 NH–CO–) in the side chain of PEI-Et, and 
peak d was assigned to the methylene protons of (–CH2CH2 
NH–) in the backbone. In the FT-IR spectrum (Figure 3B), 
the stretching vibration at 1708 cm−1 appeared and was 
attributed to the carbamate carbonyl group of PEI-Et. The 
average molecular weight of PEI-Et measured with a GPC 
instrument was 2895 Da, with a polydispersity of 2.37. These 
results demonstrated that ethylene bis(chloroformate) was 
successfully cross-linked to PEI 800 Da.
Characterization of PEI-Et/pDNA 
complexes
The condensation of pDNA into small particles is a neces-
sary prerequisite for gene delivery using cationic polymers.22 
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Figure 2 1H-NMR spectra of PEI 800 Da (A) and PEI-Et (B).
Abbreviations: 1H-NMR, proton nuclear magnetic resonance; PEI, polyethylenimine; PEI-Et, PEI derivative with ethylene biscarbamate linkage.
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The formation of PEI-Et/pDNA complexes was based on 
electrostatic interaction between the positive amino groups 
of PEI-Et and negative phosphate groups of pDNA. The 
pDNA condensation ability of the polymer was confirmed 
by agarose gel electrophoresis. As shown in Figure 4A, the 
migration of pDNA was completely retarded when w/w ratio 
reached approximately three, indicating that pDNA was com-
pletely complexed with PEI-Et at w/w ratios $ 3. Interaction 
of DNA or small interfering RNA (siRNA) with cationic 
polymers could protect the condensed pDNA or siRNA 
from enzymatic degradation,23,24 making it more effective for 
cellular   transfection. However, PEI 800 Da as the backbone 
of PEI-Et could not retard the migration of pDNA even at a 
w/w ratio of 30 (Figure 4B), indicating that PEI 800 Da was 
incapable of forming complexes with pDNA.
The particle size of the polymer/pDNA complexes was a 
critical factor for gene carriers and could affect the transfection 
efficiency.25 A positive surface charge of untargeted polyplexes 
was necessary for binding to the negatively charged cellular 
membrane, which in turn facilitated uptake into the cell.26–28 
Figure 5A showed that at a w/w ratio of 0.5, the particle size 
of PEI-Et/pDNA complexes was 379 nm, the zeta potential 
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Figure 3 FT-IR spectra of PEI 800 Da (A) and PEI-Et (B).
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was 2 mV , indicating poor complexation between pDNA and 
PEI-Et. However, with an increase in w/w ratio from 1 to 30, 
PEI-Et could efficiently condense pDNA into nanoparticles 
with relatively constant diameters ranging from 130 nm to 
180 nm, suggesting the formation of stable complexes with 
a size appropriate for gene   delivery. At the same time, zeta 
potential ranged from 5 mV to 10 mV . In the case of PEI 
800 Da (Figure 5B), the particle size decreased drastically with 
increasing w/w ratio. PEI 800 Da formed loose complexes 
with a size of approximately 400 nm even at w/w 30. The zeta 
potential was negative at w/w from 0.5 to 30. These results 
also confirmed the results of the gel retardation assay.
Figure 6 showed representative morphologies of 
PEI-Et/pDNA complexes under AFM. The result indicated 
that the complexes were spherically shaped with diameters 
of 110–190 nm, which was in agreement with the particle 
size using dynamic light scattering.
Cytotoxicity assay
Cytotoxicity was a major hurdle for clinical feasibility of 
polycationic gene carriers.29 There were at least two types 
of cytotoxicity mediated by PEI-Et: an immediate toxicity 
associated with free PEI-Et and a delayed toxicity associated 
with PEI-Et/pDNA complexes. In this study, free polymers 
as well as polymer/pDNA complexes were selected to mea-
sure the cytotoxicity. Free polymers were used to simulate a 
worst case scenario and obtain larger sensitivity results, since 
toxicity was reduced when polymer/pDNA complexes were 
formed.26 Cytotoxicity profiles were analyzed by MTT assay 
in COS-7, BRL-3A, and HeLa cell lines.
Figure 7 indicated that PEI 800 Da and PEI 800 Da/
pDNA complexes showed very low cytotoxicity. The cell 
viabilities were over 91% at the tested concentrations or 
w/w ratios. PEI-Et exhibited much lower cytotoxicity than 
PEI 25 kDa at the same concentration in three different cell 
lines. In   addition, PEI-Et produced almost no   cytotoxicity 
at   concentrations below 50 µg/mL. The cell viabilities 
were 103% ± 7%, 94% ± 6%, and 98% ± 1% at a polymer 
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Figure 4 Agarose gel electrophoresis of PEI-Et/pDNA (A) and PEI 800 Da/pDNA (B) complexes at various w/w ratios.
Notes: Lane 1, Marker; Lane 2, naked pDNA; Lanes 3–10: polymer/pDNA complexes at w/w ratios of 1, 3, 5, 7, 10, 15, 20, 30.
Abbreviations: pDNA, plasmid DNA; PEI, polyethylenimine; PEI-Et, PEI derivative with ethylene biscarbamate linkage.
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concentration of 5 µg/mL in COS-7, BRL-3A, and HeLa 
cells, respectively. And these values slightly decreased to 
81% ± 9%, 91% ± 4%, and 98% ± 3%, respectively with 
the polymer concentration increasing to 50 µg/mL, which 
implied that a wide dose range of PEI-Et may be used for gene 
delivery. However, the cell viability attenuated drastically 
when the concentrations exceeded 50 µg/mL, exhibiting a 
concentration-dependent property. In contrast, cell viability 
decreased remarkably with increasing concentrations of 
PEI 25 kDa. For example, the cell viabilities were from 
77% ± 6%, 88% ± 2%, and 73% ± 5% at a PEI 25 kDa 
concentration of 5 µg/mL to 41% ± 6%, 23.11% ± 1%, and 
23.71% ± 1% at a PEI 25 kDa concentration of 100 µg/mL 
in COS-7, BRL-3A, and HeLa cells, respectively. For the 
cell viabilities of polymer/pDNA complexes, PEI-Et/pDNA 
complexes also displayed remarkably low cytotoxicity than 
PEI 25 kDa/pDNA complexes among the three cell lines.
Generally, the cytotoxicity of cationic polymer was a 
consequence of polymer aggregation on the cell surface due 
to strong electrostatic interactions in the plasma membrane, 
which impaired cell membrane function.11,30 The molecular 
weight was a major factor affecting the cytotoxicity of PEI, 
low-molecular-weight PEI produced lower cytotoxicity when 
compared with high-molecular-weight PEI.12 For this reason, 
PEI-Et with much lower cytotoxicity was probably due to 
the significantly lower molecular weight than PEI 25 kDa. 
This was in agreement with a study Bieber and Elsasser31 
previously reported, Bieber separated high-molecular-weight 
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Figure 8 Transfection efficiency of PEI-Et/pGL3-Control complexes at various w/w ratios in serum-free medium in (A) COS-7, (B) BRL-3A, and (C) HeLa cell lines, and 
(D) transfection efficiency of PEI-Et/pGL3-Control complexes (w/w 20) in serum-containing medium in the three cell lines, in comparison with that of PEI 25 kDa (w/w 2), 
Lipofectamine 2000 (w/w 1), and PEI 800 Da (w/w 2).
Notes: n = 3, error bars represent standard deviation, *P , 0.05, **P , 0.01.
Abbreviations: N, naked pDNA; 25k, PEI 25 kDa; L, Lipofectamine 2000; PEI, polyethylenimine; PEI-Et, PEI derivative with ethylene biscarbamate linkage.
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PEI into fractions of different molecular weight by gel filtra-
tion chromatography (GFC) and found a positive correlation 
between cytotoxicity and molecular weight. Our results 
demonstrated that PEI-Et was a very promising material for 
safe gene delivery compared to PEI 25 kDa.
Transfection experiments in vitro
Luciferase activity assay
To investigate the in vitro gene delivery efficiency of 
PEI-Et, we performed luciferase activity assays, using 
three   different cell lines described above. PEI 800 Da, 
PEI 25 kDa, and Lipofectamine 2000 at optimal w/w were 
used as positive controls. As illustrated in Figure 8A–C, 
transfection efficiency of the polymer was dependent on 
the cell line, and the highest transfection efficiency was 
obtained in HeLa cell line. Naked pDNA yielded almost 
negligible luciferase expression, implying that pDNA 
without any carrier exhibited fairly low transfection effi-
ciency according to the study reported previously.32,33 Also, 
interestingly, transfection efficiency of PEI-Et increased 
Figure 9 Fluorescence images (A) and flow cytometry analyzed graphs (B) of cell distribution expressing GFP of HeLa cells transfected with (a) PBS (negative control), (b) 
PEI-Et/pEGFP-N1 (w/w 20), (c) PEI 25 kDa/pEGFP-N1 (w/w 2) (magnification, 100× ), and (C) transfection efficiency of PEI-Et and PEI 25 kDa as a percentage of EGFP positive 
cells per total amount of HeLa cells.
Notes: n = 3, error bars represent standard deviation, *P , 0.05.
Abbreviations: PEI, polyethylenimine; PEI-Et, PEI derivative with ethylene biscarbamate linkage.
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with increasing w/w ratios below 20, and then decreased 
at higher w/w ratios in all the three cell lines. This phe-
nomenon could be explained that a low w/w ratio would 
yield physically unstable complexes and poor transfection, 
whereas a high w/w ratio resulted in a poor transfection 
due to their stability, thus, the pDNA could not be released 
from the complexes.
In addition, PEI-Et/pDNA complexes at w/w ratio 
20 showed a 3.4-fold higher transfection efficiency in com-
parison to PEI 25 kDa at its optimal w/w ratio 2 in COS-7 cells 
(P , 0.01). In BRL-3A cells, PEI-Et /pDNA complexes at 
w/w 20 resulted in a 2.6-fold higher transfection efficiency in 
comparison to PEI 25 kDa at its optimal w/w 2 (P , 0.01). In 
HeLa cells, PEI-Et/pDNA complexes at w/w 20 resulted in a 
3.5-fold higher transfection efficiency than PEI 25 kDa at its 
optimal w/w 2 (P , 0.01), and 25-fold higher transfection 
efficiency than Lipofectamine 2000 at its optimal w/w ratio 1 
(P , 0.01). No statistically significant differences existed 
between the data of complexes at w/w ratio 20 and the data 
of the Lipofectamine 2000 at its optimal w/w ratio 1 in both 
COS-7 and BRL-3A cells (P . 0.05). Transfection was also 
performed in serum-containing medium, and w/w 20 for 
PEI-Et/pDNA complexes that produced the highest trans-
fection efficiency in serum-free condition was selected. As 
shown in Figure 8D, for all the polymers, the presence of 
serum inhibited the transfection activity. This was possibly 
due to the binding of the positively charged polymer/pDNA 
complexes with the negatively charged serum proteins that 
would reduce the cellular uptake of complexes.34 However, 
PEI-Et/pDNA complexes still exhibited much higher trans-
fection efficiency than PEI 25 kDa (P , 0.05), Lipofectamine 
2000 (P , 0.01) and PEI 800 Da (P , 0.01) in the three cell 
lines. The enhanced transfection efficiency of PEI-Et than 
PEI 25 kDa was probably due to the weaker condensation 
capability of PEI-Et than PEI 25 kDa, which would lead to 
an easy release of pDNA from the complexes after passing 
through the cell membrane. Moreover, the reduced cytotox-
icity would also facilitate the transfection efficiency. These 
results indicated that the polymer was more efficient as a gene 
carrier, compared with the commercial transfection reagent 
PEI 25 kDa, which was considered as the most popular 
“gold standard” in gene transfection, and was comparable 
to Lipofectamine 2000.
Fluorescence microscopy and fluorescence-activated  
cell-sorting analysis
To confirm the enhanced transfection efficiency of PEI-Et 
than commercially available PEI 25 kDa, gene delivery 
efficiency was evaluated in HeLa cells, using pEGFP-N1 as 
a reporter gene. PEI-Et/pDNA (w/w 20) and PEI 25 kDa/
pDNA (w/w 2) were selected based on the luciferase activity 
assay. In the fluorescence microscope images (Figure 9A), 
the cells transfected with PEI-Et/pEGFP-N1 displayed more 
bright green fluorescent spots than PEI 25 kDa/pEGFP-N1. 
Furthermore, the transfection efficiency was quantified using 
flow cytometry in terms of cell population expressing GFP. 
As shown in Figure 9C, transfection efficiency of PEI-Et/
pDNA (33%) was higher than that of PEI 25 kDa/pDNA 
(27%), with P , 0.05. These results accorded well with the 
luciferase activity assays, indicating the superiority of PEI-Et 
over PEI 25 kDa.
Conclusion
In the present study, a novel PEI derivative PEI-Et linked 
through biscarbamate linkages was successfully prepared 
and evaluated as nonviral gene carriers. The PEI-Et was 
synthesized by a simple chemical procedure, carried the 
enhanced ability to condense pDNA into nanoparticles and 
physicochemical properties appropriate for gene delivery. 
The polymer exhibited much lower cytotoxicity and signifi-
cantly enhanced transfection efficiency in various cell lines 
when compared to commercially available PEI 25 kDa. 
Therefore, it is reasonable to conclude that PEI-Et would 
be a promising strategy for safe and efficient gene delivery 
in gene therapy.
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